Publication: Epigenetic and post-transcriptional regulation of somatostatin receptor subtype 5 (SST5 ) in pituitary and pancreatic neuroendocrine tumors.
Loading...
Identifiers
Date
2021-09-06
Authors
Pedraza-Arevalo, Sergio
Ibañez-Costa, Alejandro
Blazquez-Encinas, Ricardo
Branco, Miguel R
Vazquez-Borrego, Mari C
Herrera-Martinez, Aura D
Venegas-Moreno, Eva
Serrano-Blanch, Raquel
Arjona-Sanchez, Alvaro
Galvez-Moreno, Maria A
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
John Wiley & Sons
Abstract
Somatostatin receptor subtype 5 (SST5 ) is an emerging biomarker and actionable target in pituitary (PitNETs) and pancreatic (PanNETs) neuroendocrine tumors. Transcriptional and epigenetic regulation of SSTR5 gene expression and mRNA biogenesis is poorly understood. Recently, an overlapping natural antisense transcript, SSTR5-AS1, potentially regulating SSTR5 expression, was identified. We aimed to elucidate whether epigenetic processes contribute to the regulation of SSTR5 expression in PitNETs (somatotropinomas) and PanNETs. We analyzed the SSTR5/SSTR5-AS1 human locus in silico to identify CpG islands. SSTR5 and SSTR5-AS1 expression was assessed by quantitative real-time PCR (qPCR) in 27 somatotropinomas, 11 normal pituitaries (NPs), and 15 PanNETs/paired adjacent (control) samples. We evaluated methylation grade in four CpG islands in the SSTR5/SSTR5-AS1 genes. Results revealed that SSTR5 and SSTR5-AS1 were directly correlated in NP, somatotropinoma, and PanNET samples. Interestingly, selected CpG islands were differentially methylated in somatotropinomas compared with NPs. In PanNETs cell lines, SSTR5-AS1 silencing downregulated SSTR5 expression, altered aggressiveness features, and influenced pasireotide response. These results provide evidence that SSTR5 expression in PitNETs and PanNETs can be epigenetically regulated by the SSTR5-AS1 antisense transcript and, indirectly, by DNA methylation, which may thereby impact tumor behavior and treatment response.
Description
MeSH Terms
DNA methylation
Epigenesis, genetic
Humans
Neuroendocrine tumors
Pancreatic neoplasms
Pituitary neoplasms
Receptors, somatostatin
Epigenesis, genetic
Humans
Neuroendocrine tumors
Pancreatic neoplasms
Pituitary neoplasms
Receptors, somatostatin
DeCS Terms
Epigénesis genética
Metilación de ADN
Neoplasias hipofisarias
Neoplasias pancreáticas
Receptores de somatostatina
Tumores neuroendocrinos
Metilación de ADN
Neoplasias hipofisarias
Neoplasias pancreáticas
Receptores de somatostatina
Tumores neuroendocrinos
CIE Terms
Keywords
SST5, Epigenetics, Natural antisense transcript, Neuroendocrine tumors, Pancreas, Pituitary
Citation
Pedraza-Arevalo S, Ibáñez-Costa A, Blázquez-Encinas R, Branco MR, Vázquez-Borrego MC, Herrera-Martínez AD, et al. Epigenetic and post-transcriptional regulation of somatostatin receptor subtype 5 (SST5 ) in pituitary and pancreatic neuroendocrine tumors. Mol Oncol. 2022 Feb;16(3):764-779